首页> 外文OA文献 >ARF mutation accelerates pituitary tumor development in Rb+/− mice
【2h】

ARF mutation accelerates pituitary tumor development in Rb+/− mice

机译:ARF突变加速Rb +/-小鼠垂体肿瘤的发展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mice heterozygous for the retinoblastoma (Rb) tumor suppressor gene develop pituitary and thyroid tumors with high penetrance. We demonstrate here that loss of the ARF tumor suppressor strongly accelerates intermediate lobe pituitary tumorigenesis in Rb heterozygous mice. These effects in the pituitary are greater than those conferred by p53 loss in that Rb+/−;ARF−/− mice display significantly more early atypical lesions than Rb+/−; p53−/− mice. Also, Rb+/−;ARF−/− compound mutants do not develop many of the novel tumors or precancerous lesions seen in Rb+/−;p53−/− compound mutants. Although complete loss of ARF expression is not obligatory for pituitary tumorigenesis in Rb+/− mice, alterations of the ARF locus are observed in tumors from Rb+/−;ARF+/− mice, consistent with a selective advantage of ARF inactivation in this context. We conclude that inactivation of ARF acts more broadly than that of p53 in connecting abrogation of the Rb pathway to tumorigenesis.
机译:视网膜母细胞瘤(Rb)肿瘤抑制基因的杂合小鼠会发展出高穿透性的垂体和甲状腺肿瘤。我们在这里证明,ARF肿瘤抑制因子的丧失强烈地加速了Rb杂合小鼠的中间叶垂体垂体肿瘤发生。垂体的这些作用大于p53丧失所引起的作用,因为Rb +/-; ARF-/-小鼠比Rb +/-表现出明显更多的早期非典型病变。 p53-/-小鼠。同样,Rb +/- ARF-/-复合突变体不会发展出在Rb +/- p53-/-复合突变体中发现的许多新型肿瘤或癌前病变。尽管在Rb +/-小鼠中垂体肿瘤发生中ARF表达的完全丧失不是强制性的,但在Rb +/- ARF +/-小鼠的肿瘤中观察到了ARF基因座的改变,与ARF失活在此背景下的选择性优势相一致。我们得出结论,在将Rb途径废止与肿瘤发生联系起来时,ARF的失活作用比p53的作用更广泛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号